Cite
HARVARD Citation
Kuhle, J. et al. (2022). Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. Multiple sclerosis. pp. 573-582. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kuhle, J. et al. (2022). Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. Multiple sclerosis. pp. 573-582. [Online].